In 2015, Wu et al. published a SAR study of a potent 2-thiohydantoinderivative (62) as a cancer-associated mutant IDH-1 inhibitor.63 A total of 37 compounds were furnished withvarious substitutions, and their activity was evaluated against IDH1(R132H). The gene discussed is IDH1; the disease is cancer.